Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

類似資料

• Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
  著者:: Mohty, Mohamad, 等
  出版事項: (2017)
• Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC
  著者:: Le Bourgeois, Amandine, 等
  出版事項: (2018)
• Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS
  著者:: Chevallier, Patrice, 等
  出版事項: (2016)
• Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia
  著者:: Talbot, Alexis, 等
  出版事項: (2014)
• Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
  著者:: Saraceni, Francesco, 等
  出版事項: (2017)